X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEVA PHARMA (Israel) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   TEVA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-18
TEVA PHARMA
Dec-13
NOVARTIS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs7582,872-   
Low Rs5792,495-   
Sales per share (Unadj.) Rs228.41,648.4-  
Earnings per share (Unadj.) Rs31.7103.0-  
Cash flow per share (Unadj.) Rs32.8236.2-  
Dividends per share (Unadj.) Rs10.0090.14-  
Dividend yield (eoy) %1.53.4 44.5%  
Book value per share (Unadj.) Rs297.11,831.0-  
Shares outstanding (eoy) m24.69848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.6 179.8%   
Avg P/E ratio x21.126.1 80.8%  
P/CF ratio (eoy) x20.411.4 179.6%  
Price / Book Value ratio x2.21.5 153.5%  
Dividend payout %31.587.5 36.0%   
Avg Mkt Cap Rs m16,5052,275,684 0.7%   
No. of employees `0000.744.9 1.5%   
Total wages/salary Rs m1,4450-   
Avg. sales/employee Rs Th8,441.331,100.4 27.1%   
Avg. wages/employee Rs Th2,163.60-   
Avg. net profit/employee Rs Th1,173.11,942.8 60.4%   
INCOME DATA
Net Sales Rs m5,6391,397,806 0.4%  
Other income Rs m1,7180-   
Total revenues Rs m7,3571,397,806 0.5%   
Gross profit Rs m-63382,790 -0.0%  
Depreciation Rs m25112,986 0.0%   
Interest Rs m5527,455 0.2%   
Profit before tax Rs m1,575242,349 0.6%   
Minority Interest Rs m01,101 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-159,089 0.0%   
Tax Rs m792-2,959 -26.8%   
Profit after tax Rs m78487,320 0.9%  
Gross profit margin %-1.127.4 -4.0%  
Effective tax rate %50.3-1.2 -4,116.1%   
Net profit margin %13.96.2 222.5%  
BALANCE SHEET DATA
Current assets Rs m9,522944,073 1.0%   
Current liabilities Rs m3,296823,312 0.4%   
Net working cap to sales %110.48.6 1,277.9%  
Current ratio x2.91.1 251.9%  
Inventory Days Days3791 40.3%  
Debtors Days Days2896 29.6%  
Net fixed assets Rs m46456,554 0.0%   
Share capital Rs m1233,441 3.6%   
"Free" reserves Rs m7,2130-   
Net worth Rs m7,3361,552,698 0.5%   
Long term debt Rs m0714,729 0.0%   
Total assets Rs m11,1053,194,435 0.3%  
Interest coverage x29.59.8 300.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 116.0%   
Return on assets %7.63.6 210.2%  
Return on equity %10.75.6 189.9%  
Return on capital %22.24.9 450.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,5700-   
CASH FLOW
From Operations Rs m1,610222,738 0.7%  
From Investments Rs m687-78,925 -0.9%  
From Financial Activity Rs m-2,677-267,189 1.0%  
Net Cashflow Rs m-380-123,376 0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.81 Rs / USD

Compare NOVARTIS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare NOVARTIS With: WYETH LTD  SHASUN PHARMA  PIRAMAL ENTERPRISES  TORRENT PHARMA  ALEMBIC LTD  



Today's Market

Sensex Opens in Green; TCS and Bharti Airtel Top Gainers(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.7% while the Hang Seng is up 1.1%.

Related Views On News

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock (The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 19, 2019 09:53 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE NOVARTIS WITH

MARKET STATS